R3(TM) 28 MM I.D., 60 MM O.D. CONSTRAINED LINER, REF 71339160, QTY: (1), STERILE EO, Product Usage: The R3 Constrained liner Acetabular System is a cemented or uncemented prosthesis intended to replace a hip joint. The Constrained liner is intended for primary or revision patients at high risk for hip dislocation due to a history of prior dislocation, bone loss, soft tissue laxity, neuromuscular disease, or intra-operative instability and for whom all other options to constrained acetabular components have been considered. The R3 Constrained liner is intended for single use only.
Publicado el 17 de junio de 2015 · Inicio del retiro: 6 de mayo de 2015
Resumen
FDA registra el retiro Z-1738-2015 de dispositivos médicos de Clase II, publicado el 17 de junio de 2015 e iniciado el 6 de mayo de 2015. Empresa responsable: Smith & Nephew, Inc.; Estado: Finalizado; Cantidad reportada: 40 units; Lote: Lot numbers: 16HM08087, 14HM08097, 14HM08133, 14HM08141, and 14JM21517. La Clase II indica posibles consecuencias temporales o médicamente reversibles, o una probabilidad remota de consecuencias graves.
Estado reportado al momento de publicación: Terminated — openFDA actualiza semanalmente y este campo no refleja el estado más reciente. Confirma siempre con la fuente oficial.
Qué peligro representa
The R3 Constrained outer liner locking groove diameter is 0.030 inches oversized and may not allow the locking ring to engage into the R3 shell.
Qué hacer
Voluntary: Firm initiated · Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit
Recibe un correo cuando FDA publique un retiro como este
Gratis. Solo te escribimos cuando hay un retiro nuevo que coincide. Te das de baja con un clic.
Detalles del retiro
- Fabricante
- Smith & Nephew, Inc.
- Distribuidor
- Worldwide Distribution - US Nationwide in the states of CA, FL, IL, IN, MI, NE, NY, TN, TX, VA, WI and the countries of Australia, Switzerland, Chile, Canada, and Spain
- Lote
- Lot numbers: 16HM08087, 14HM08097, 14HM08133, 14HM08141, and 14JM21517
- Clasificación de riesgo
- Class II
- Área (FDA)
- device
- País
- United States
Retiros relacionados
- FDAEVOS 3.5MM LATERAL PROXIMAL TIBIA PLATE 6 HOLE LEFT 91MM REF7246310611 de noviembre de 2026
- FDATRIGEN PROXIMAL STRAIGHT HUMERAL NAIL 8/7 X 16, REF: 7176081624 de junio de 2026
- FDABIOSURE HA SCREW, 6MM x 20 MM. Threaded metallic bone fixation fastener.24 de diciembre de 2025
- FDATandem Intl Bipolar Cocr Shell/UHMWPE Liner, TI-6AL-4V Retaining Ring, 28MM I.D. 46 MM O.D., REF 71324046,13 de noviembre de 2024
- FDAVITROS 5,1 FS Chemistry System, Software Version 2.8 & Below Automates pre-analytical and post-analytical17 de junio de 2015
- FDAUnilateral external fixation ankle clamp Product Usage: Unilateral external fixation for use treatment of bone17 de junio de 2015
Preguntas sobre este retiro
¿R3(TM) 28 MM I.D., 60 MM O.D. CONSTRAINED LINER, REF 71339160, QTY: (1), STERILE EO, Product Usage: The R3 Constrained liner Acetabular System is a cemented or uncemented prosthesis intended to replace a hip joint. The Constrained liner is intended for primary or revision patients at high risk for hip dislocation due to a history of prior dislocation, bone loss, soft tissue laxity, neuromuscular disease, or intra-operative instability and for whom all other options to constrained acetabular components have been considered. The R3 Constrained liner is intended for single use only. fue retirado del mercado?
Sí. FDA publicó el retiro Z-1738-2015 el 17 de junio de 2015. Peligro reportado: The R3 Constrained outer liner locking groove diameter is 0.030 inches oversized and may not allow the locking ring to engage into the R3 shell.
¿Qué debo hacer si tengo este producto?
Voluntary: Firm initiated · Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit